| <p>Oxygenta Pharmaceutical Limited informed the BSE Limited that the trading window for dealing in the company's securities will be closed from October 1, 2026, until 48 hours after the declaration of financial results for the quarter and half year ending September 30, 2026, for designated persons, their immediate relatives, and connected persons, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015; a board meeting will be scheduled to consider and approve the financial results.</p> |